The second most commonly reported type of drug-associated CTCL in this review was PC-ALCL, another member of the CD30-positive lymphoproliferative disorder family [4, 78]. Here, TNFRSF8 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.